Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre and Section of Cardiology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Can J Cardiol. 2013 Mar;29(3):304-16. doi: 10.1016/j.cjca.2012.11.001. Epub 2013 Jan 17.
There have been major technological advances in echocardiography over the past decade. New and robust measures of myocardial function, both systolic and diastolic, have been identified and extensively evaluated. Some of the new measures such as annular velocities by tissue Doppler imaging have become an integral part of the echocardiographic examination, and other measures such as strain and strain rate have yet to be widely adopted. Three-dimensional (3D) echocardiography has evolved greatly since its introduction in the 1980s. Currently, its main clinical application is the perioperative assessment of the mitral valve. Though 3D echocardiography provides superior quantification of cardiac chamber size, its adoption has been limited by the lack of robust automated data analysis software with smooth integration of analysis packages into clinical workstations and suboptimal temporal and spatial resolution. With advancement in electronics and miniaturization, these limitations can be overcome. The history of contrast echocardiography is long and arduous. Use of a microbubble contrast for left ventricular opacification has become commonplace in most echocardiographic laboratories, but the routine use of microbubble contrast for myocardial perfusion will require standardization of the procedure and/or development of new contrast agents. The applications of 3D and microbubble contrast are also under active evaluation in vascular ultrasound. This review summarizes the current and future applications of these exciting developments in echocardiography and vascular ultrasound.
在过去的十年中,超声心动图技术取得了重大进展。已经确定并广泛评估了新的、稳健的心肌收缩和舒张功能指标。一些新的指标,如组织多普勒成像的瓣环速度,已成为超声心动图检查的一个组成部分,而其他指标,如应变和应变速率,尚未得到广泛采用。自 20 世纪 80 年代问世以来,三维(3D)超声心动图已经有了很大的发展。目前,其主要的临床应用是二尖瓣围术期评估。尽管 3D 超声心动图提供了对心脏腔室大小的更好量化,但由于缺乏强大的自动化数据分析软件,以及分析软件包与临床工作站的顺利集成,以及时空分辨率不理想,其应用受到限制。随着电子技术和小型化的进步,这些限制可以得到克服。对比超声心动图的历史悠久而艰难。微泡对比剂用于左心室显影已在大多数超声心动图实验室中普遍使用,但微泡对比剂用于心肌灌注的常规使用需要对该程序进行标准化,或开发新的对比剂。3D 和微泡对比剂的应用也在血管超声中得到了积极的评估。本综述总结了超声心动图和血管超声中这些令人兴奋的发展的当前和未来应用。